Znn3bq.jpeg
²é¿´: 3401  |  »Ø¸´: 97
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û86´Î£¬×÷ÕßtmxklÔö¼Ó½ð±Ò 66.25 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

tmxkl

ľ³æ (ÕýʽдÊÖ)


[×ÊÔ´] Ó¢ÎÄÕªÒªµÄÐÞ´Ç(×ªÔØ)

(1) ÕªÒªÖеĵÚÒ»¾ä»°²»ÒªÓëÎÄÌâÖØ¸´,ÒªÓÐËù±ä»¯£¬²¹³äһЩϸ½Ú¡£ÈçÎÄÌâΪ£ºExpression of RACK1 in primary colon cancers. ÔòÕªÒªµÚÒ»¾ä»°²»ÒªÐ´ÎªTo detect the expression of RACK1 in primary colon cancers. ×îºÃ¸ÄΪTo detect RACK1 gene over-expressed in primary colon carcinoma by in situ hybridisation.

(2) ¿ÉÓö¯´ÊµÄÇé¿öÓ¦¾¡Á¿±ÜÃâÓ¦Óö¯´ÊµÄÃû´ÊÐÎʽ¡£Èç: Ó¦µ±ÓÃHer-2 oncogene amplification in prostate cancer was measured. ¶ø²»ÓÃMeasurement of Her-2 oncogene amplification in prostate cancer was made.

(3) ÕýȷʹÓùڴʣ¬°üÀ¨¶¨¹Ú´ÊtheºÍ²»¶¨¹Ú´Êa»ò an£»Çø·Ö¿ÉÊýÃû´ÊºÍ²»¿ÉÊýÃû´ÊÊǹؼü¡£Èçexpression×ö£¨»ùÒò£©±í´ïÓÃʱΪ²»¿ÉÊýÃû´Ê£¬²»Äܼӡ°s¡±. ¶Ô¿ÉÊýÃû´Ê¾¡¿ÉÄÜʹÓÃÆä¸´ÊýÐÎʽ¡£

(4) Ó¦µ±ÓÃÔ¤ÖöÌÓï·Ö¿ª»òÓÃÁ¬×Ö·û¶Ï¿ªÃû´Ê´Ê×飬±ÜÃâʹÓÃÁ¬Ðø¶à¸öÐÎÈÝ´Ê»òÃû´ÊÀ´ÐÞÊÎÃû´Ê¡£ÈçÓÃsections of formalin-fixed and paraffin-embedded tissues, ¶ø²»ÓÃformalin fixed and paraffin embedded tissue sections¡£

(5) ×¢ÒâÆ½Ðнṹ£ºÔÚ±íÊö¸÷ÏàͬµÄ²¢ÁгɷÖʱ£¬²»ÂÛÊÇ´ÊÀà¡¢´Ê×é¡¢´Ó¾ä»ò·Ö¾ä£¬Ã¿¸ö³É·Ö¶¼±ØÐë¶ÔµÈ¡£ÈçThe purpose of this study was to analyze the new proposed classification and determining which classification was clinically useful. ÆäÖеڶþ¸ö±íÓïÊǶ¯Ãû´Ê¶ÌÓÓëµÚÒ»¸ö±íÓï²»¶¨Ê½¶ÌÓï²»Ò»Ö£¬²»·ûºÏƽÐнṹԭÔò¡£

(6) ±È½Ï±ØÐëÔÚͬÀàµÄÊÂÎïÖ®¼ä½øÐУ¬ÇмɶԲ»Í¬ÀàÐÍÊÂÎï½øÐбȽϡ£ÀýÈ磺The survival of patients with MSI+ phenotype was better than MSI- phenotype. ´Ë¾ä±È½Ï¶ÔÏ󲻶Եȣ¬Ó¦¸ÄΪThe survival of patients with MSI+ phenotype was better than that of patients with MSI- phenotype.

Ó¢ÎÄÕªÒªµÄÎÄÌå

(1) Òª¿Í¹ÛµØÐðÊö·½·¨ºÍ½á¹û, ÓôÊÒªÖÊÆÓÎÞ»ª, ±ÜÃâʹÓôø¸ÐÇéÉ«²Ê»ò¹ã¸æÊ½Ðû´«µÄ´ÊÓï¡£²»ÒËдÀàËÆÏÂÁеľä×Ó£ºA very interesting example is found that ¡­; The staining yields excellent results; The method is very useful for ¡­ .

(2) ʹÓÃÕýʽÎÄÌå, ²»ÓÿÚÓïÌåºÍ·Ç¹æ·¶Ëõд´Ê¡£Èçisn¡¯t, aren¡¯t, hadn¡¯t, hadn¡¯t, haven¡¯t, don¡¯t, can¡¯t, wouldn¡¯t, a lot of, a bit, too(also), thru(through), exam (examination), lab(laboratory)µÈ¡£

(3) Ôì¾äʱ¾¡Á¿Ê¹¶¯´Ê¿¿½üÖ÷Óï¡£È磺ÓÃOur results are in contradiction with these observations because 53% of our MFH-like PLPs and 10% of epithelioid PLPs were immunoreactive for CD34. ¶ø²»ÓÃOur results that 53% of MFH-like PLPs and 10% of epithelioid PLPs were immunoreactive for CD34, are in contradiction with these observations.

(4) ¾¡Á¿Ó¦ÓÃÖØÒªÊÂʵ¿ªÍ·£¬±ÜÃâ¶ÌÓï»ò´Ó¾ä¿ªÍ·¡£ÈçMCMV tended to infect GFAP-positive glial cells in the periventricular area during acute infection in the present study. ¶ø²»ÓÃIn the present study, during acute infection, MCMV tended to infect GFAP-positive glial cells in the periventricular area.

(5) ÕªÒªÖ»ÏÞ±íʾÐÂÏûÏ¢¡¢ÐÂÄÚÈÝ£¬Ó¦¼õÉÙ»òÈ¡Ïû¶Ô¹ýÈ¥Ñо¿Çé¿öµÄÃèÊö£¬¼õÉÙ»òÈ¡Ïû²»±ØÒªµÄ±³¾°ÐÅÏ¢¡£ÕªÒªÒ²²»Ó¦°üÀ¨×÷Õß¶ÔδÀ´µÄ¼Æ»®£¬Èç¡°ÓйØXXX·½ÃæµÄÑо¿ÓдýÓÚ½øÒ»²½¿ªÕ¹¡±µÈ¡£

(6) Ê¡ÂÔ¡£Îª±ÜÃâÖØ¸´ºÍËõСժҪµÄƪ·ù£¬¿Æ¼¼Ó¢Óï¶à²ÉÓÃÊ¡ÂÔµÄд·¨¡£ÔÚ²¢Áи´ºÏ¾äÀºóÃæ·Ö¾äÈçÓëÇ°Ãæ·Ö¾äÏàͬµÄ²¿·Ö£¬ÍùÍù¿ÉÒÔÊ¡ÂÔ¡£³£¼ûµÄÊÇνÓﶯ´ÊÊ¡ÂÔ£¬ÔÚÊ¡ÂÔ´¦¿ÉÓûò²»ÓöººÅ·Ö¿ª¡£È磬Despite vaccination, one patient developed pneumococcal menigitis and another, pneumococcal bacteremia. ´ËÍ⣬ÓÃwhen, while, if, as, though (although)ºÍwhether µÈÁ¬´ÊÁ¬½ÓµÄʱ¼ä¡¢Ìõ¼þ¡¢·½Ê½¡¢Èò½µÈ´Ó¾ä£¬ÈçÆäνÓïÖÐÓÐbe£¬¶øÇÒÆäÖ÷ÓïÓëÖ÷¾äµÄÖ÷ÓïÏàͬ»òΪitʱ£¬´Ó¾äµÄÖ÷ÓïºÍbeÒ²¿ÉÒÔÊ¡ÂÔ¡£

(7) ±ÜÃâʹÓá°Ðü´¹·Ö´Ê¡±(hanging participle). ʹÓÃûÓÐÂß¼­Ö÷ÓïµÄ·Ö´Ê¶ÌÓï×ö×´ÓÊÇÒ»ÖÖ×î³£¼ûµÄÐÞ´Ç´íÎó£¬ÀýÈç: Following his advice, the bacteria were stained with thionin. ӦдΪFollowing his advice, we stained the bacteria with thionin. »òIn accordance with his advice the bacteria were stained with thionin.

(8) ±ÜÃâÊÇһЩº¬ÒåÄ£ºýµÄÐÎÈÝ´Ê»ò¸±´Ê¡£Èç: considerable, appreciable, substantial, very, relatively, comparatively, essentially, duly, somewhat, rather, necessarily, inevitably µÈ¡£

(9) ɾ·±¾Í¼ò£¬Ó¦µ±ÓúÏÊʵĶÌÓï´úÌæ×Ӿ䣬ÓúÏÊʵĵ¥´Ê´úÌæ¶ÌÓï¡£Èç: ÓÃincreased ´úÌæhas been found to increase, ÓÃwas´úÌæwas considered to be, ÓÃseemingly´úÌæit would seem that, µÈµÈ¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

limingtiaan2

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¡¾ÆÀ¼Û¡¿¡ï¡ï¡ï¡ï¡ï (ÎåÐǼ¶,ÓÅÐãÍÆ¼ö)

  
лл·ÖÏí£¡
14Â¥2008-07-15 08:23:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 98 ¸ö»Ø´ð

bzhshb

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ÖµµÃÎÒÃÇ´ó¼ÒÈ¥ºÃºÃ¿´Ò»Ï ллÌṩ°¡
8Â¥2008-07-14 20:27:23
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wdbyxr

ľ³æ (ÖøÃûдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

лл£¬×ܽáµÄºÜºÃ
9Â¥2008-07-14 21:13:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
weihui_cn2Â¥
2008-07-14 14:16   »Ø¸´  
 
snowysky11Â¥
2008-07-15 00:15   »Ø¸´  
  thx
2008-07-15 07:59   »Ø¸´  
 
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0854µ÷¼Á +9 950824he@ 2026-04-09 9/450 2026-04-16 11:11 by noqvsozv
[¿¼ÑÐ] 22408 312Çóµ÷¼Á +21 ÃÅ·ÃþÃþ 2026-04-14 22/1100 2026-04-16 10:51 by °¢Îij¬
[¿¼ÑÐ] 273Çóµ÷¼Á +6 °×¾Ó²»Ò×. 2026-04-09 8/400 2026-04-15 22:02 by wooluyong
[¿¼ÑÐ] ͨÐŹ¤³ÌÇóµ÷¼Á£¡£¡£¡ +6 zlb770521 2026-04-14 6/300 2026-04-15 20:00 by ѧԱJpLReM
[¿¼ÑÐ] ҩѧÇóµ÷¼Á +11 RussHu 2026-04-12 13/650 2026-04-15 19:07 by zhuwenxu
[¿¼ÑÐ] ʳƷÓëÓªÑø£¨0955£©271Çóµ÷¼Á +15 Éý¸ñ°¢´ï 2026-04-12 16/800 2026-04-14 13:18 by ¸¡Èô_°²Éú
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤349·ÖÇóµ÷¼Á +16 Àîľ×Ó°¡¹þ¹þ 2026-04-12 17/850 2026-04-14 09:11 by fenglj492
[¿¼ÑÐ] 305Çóµ÷¼Á +8 Â꿨°Í¿¨boom 2026-04-11 8/400 2026-04-14 09:04 by pengliang8036
[¿¼ÑÐ] ¿¼ÑÐÓ¢Ò»ÊýÒ»338·Ö +9 ³¤½­´óѧ¶«Ð£Çø 2026-04-13 10/500 2026-04-14 00:41 by Íõ¬Bè±
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] 302Çóµ÷¼Á +10 Ò×£¡? 2026-04-13 10/500 2026-04-13 19:04 by lbsjt
[¿¼ÑÐ] 339Çóµ÷¼Á +4 hanwudada 2026-04-12 4/200 2026-04-13 12:03 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 344 ²ÄÁÏרҵ Çóµ÷¼Á211 ÎÞµØÓòÒªÇó +8 hualkop 2026-04-11 8/400 2026-04-12 22:24 by fqwang
[¿¼ÑÐ] 2±¾£¬³õÊÔ303£¬0860Çóµ÷¼Á +6 floriea 2026-04-12 8/400 2026-04-12 18:13 by zhouxiaoyu
[¿¼ÑÐ] µçÆø×¨Ë¶320Çóµ÷¼Á +6 СÂé×Ó111 2026-04-10 6/300 2026-04-12 10:54 by lemon6009
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸²ÄÁÏ¿ÆÑ§Ó빤³Ì985£¬365·Ö£¬ +8 ²Ä»¯Àî¿É 2026-04-11 10/500 2026-04-12 08:42 by 852137818
[¿¼ÑÐ] ²ÄÁϹ¤³ÌÈÕÓÉúÇóµ÷¼Á +7 0856?µ÷¼Á 2026-04-10 7/350 2026-04-11 21:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 270Çóµ÷¼Á +14 ÑîÀÖ369 2026-04-11 14/700 2026-04-11 20:16 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +3 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 3/150 2026-04-10 22:23 by 286640313
[¿¼ÑÐ] 301Çóµ÷¼Á +5 149. 2026-04-10 5/250 2026-04-10 15:45 by ²ñС°×
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û